The Exocrine Pancreas in Cystic Fibrosis in the Era of CFTR Modulation: A Mini Review
- PMID: 35832587
- PMCID: PMC9271761
- DOI: 10.3389/fped.2022.914790
The Exocrine Pancreas in Cystic Fibrosis in the Era of CFTR Modulation: A Mini Review
Abstract
Cystic fibrosis (CF) is a common disorder of autosomal recessive inheritance, that once conferred a life expectancy of only a few months. Over recent years, significant advances have been made to CF therapeutic approaches, changing the face of the disease, and facilitating the partial restoration of pancreatic function. This mini review summarizes the current landscape of exocrine pancreatic management in CF and explores areas for future direction and development.
Keywords: CFTR modulators; cystic fibrosis; exocrine pancreas; pancreatitis; precision medicine.
Copyright © 2022 McKay and Ooi.
Conflict of interest statement
CO has served as a consultant and received research funding (unrelated to the content of this manuscript) from Vertex Pharmaceuticals. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Donaldson SH, Boucher RC. Pathophysiology of cystic fibrosis. Annales Nestlé. (2006) 64:101–9. 10.1159/000095374 - DOI
Publication types
LinkOut - more resources
Full Text Sources